Table 1

Patient demographic characteristics and associated drug susceptibility pattern
Demographic characteristics Total Sensitivea Resistant
INHb RIFc MDRd
Number of strains 151 67 (44.4%) 1 (0.7%) 2 (1.3%) 64 (42.4%)
Sex Male 95 47 (49.5%) 1 (1.1%) 1 (1.1%) 34 (35.8%)
Female 56 20 (35.7%) 0 1 (1.8%) 30 (53.6%)
Treatment history New cases 46 28 (60.9%) 0 0 12 (26.1%)
Retreatment 94 39 (41.5%) 1 (1.1%) 2 (2.2%) 48 (51.1%)
Unknown 11 2 (18.2%) 0 0 0
HIV status Positive 69 34 (49.3%) 0 2 (2.9%) 30 (43.5%)
Negative 76 35 (46.1%) 1 (1.3%) 0 32 (42.1%)
unknown 6 0 0 0 0

aSensitive indicates isolates susceptible to both isoniazid and rifampicin; bResistance to isonaizid only, cresistance to rifampicin only, dresistance to both isonaizid and rifampicin. Seventeen isolates did not have complete susceptibility testing results and were excluded from the table.

Gafirita et al.

Gafirita et al. BMC Clinical Pathology 2012 12:20   doi:10.1186/1472-6890-12-20

Open Data